Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Inc. Genexine currently holds 91,300,933 shares of Rezolute, Inc. (RZLT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Inc. Genexine has been a net buyer of RZLT stock. They have purchased $10.0M and sold $0 worth of shares.
Inc. Genexine's most recent insider trade was on Jul 23, 2019, when they purchased 34,482,758 shares at $0.29 per share.
Inc. Genexine serves as Executive at Rezolute, Inc. (RZLT). They have executed 2 insider transactions totaling $10.0M over their tenure at the company.
Inc. Genexine holds the position of Executive at Rezolute, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Inc. Genexine has shown a buying trading pattern, with $10.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Inc. Genexine was on Jul 23, 2019, when they purchased $10.0M worth of RZLT shares. This transaction involved 34,482,758 shares at $0.29 per share.
Inc. Genexine currently owns 91,300,933 shares of Rezolute, Inc. (RZLT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Inc. Genexine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Inc. Genexine has 2 Form 4 filings on record as an insider at Rezolute, Inc..
Set alerts for Inc. Genexine and 40,000+ other insiders.